Toggle light / dark theme

One of the most commonly mentioned questions about the differences between AI and real intelligence is that the later seems to require less data than the former in order to achieve the same performance. However, we’ll explain to you in this article that why such phenomenon is nothing but an illusion… To continue reading, please visit: https://bit.ly/2p7xN0i #artificialintelligence #machinelearning #deeplearning #neuralnetworks #data #technology

The restrictions have also brought unique challenges to scientists. Some have suspended their usual research to study the coronavirus. Others have had their work or personal lives disrupted by lab closures, travel restrictions or problems sourcing equipment and reagents from suppliers in China.

In a Nature reader poll, more than 600 of you told us that the coronavirus had affected you, your colleagues and your research. These are some of your stories.


From laboratory closures to equipment shortages, researchers worldwide tell Nature how they have been affected by the epidemic. ‘No one is allowed out’: readers tell Nature about their experiences.

Circa 2011


Most bacterial infections can be treated with antibiotics such as penicillin, discovered decades ago. However, such drugs are useless against viral infections, including influenza, the common cold, and deadly hemorrhagic fevers such as Ebola.

Now, in a development that could transform how viral infections are treated, a team of researchers at MIT’s Lincoln Laboratory has designed a drug that can identify cells that have been infected by any type of virus, then kill those cells to terminate the infection.

Do you agree.


In addition, gene-editing technologies continue to advance in precision and ease of use, allowing families to treat and ultimately cure hundreds of inheritable genetic diseases.

This metatrend is driven by the convergence of: various biotechnologies (CRISPR, Gene Therapy), genome sequencing, and artificial intelligence.